Cargando…

Focal Therapy for Prostate Cancer: Complications and Their Treatment

Focal therapy is a modern alternative to selectively treat a specific part of the prostate harboring clinically significant disease while preserving the rest of the gland. The aim of this therapeutic approach is to retain the oncological benefit of active treatment and to minimize the side-effects o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rakauskas, Arnas, Marra, Giancarlo, Heidegger, Isabel, Kasivisvanathan, Veeru, Kretschmer, Alexander, Zattoni, Fabio, Preisser, Felix, Tilki, Derya, Tsaur, Igor, van den Bergh, Roderick, Kesch, Claudia, Ceci, Francesco, Fankhauser, Christian, Gandaglia, Giorgio, Valerio, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311122/ https://www.ncbi.nlm.nih.gov/pubmed/34322516 http://dx.doi.org/10.3389/fsurg.2021.696242

Ejemplares similares

Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
por: Zattoni, Fabio, et al.
Publicado: (2021)

Radical Prostatectomy: Sequelae in the Course of Time
por: Kesch, Claudia, et al.
Publicado: (2021)

Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future Perspectives
por: Kretschmer, Alexander, et al.
Publicado: (2021)

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review
por: Heidegger, Isabel, et al.
Publicado: (2022)

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU Prostate Cancer Working Group multi-institutional study
por: Zattoni, Fabio, et al.
Publicado: (2021)

Imaging modalities in synchronous oligometastatic prostate cancer
por: Futterer, Jurgen J., et al.
Publicado: (2018)

Active surveillance in renal transplant patients with prostate cancer: a multicentre analysis
por: Soeterik, Timo F. W., et al.
Publicado: (2023)

Has the COVID-19 outbreak changed the way we are treating prostate cancer? An EAU – YAU prostate cancer working group multi-institutional study
por: Zattoni, F., et al.
Publicado: (2021)

Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis
por: Kesch, Claudia, et al.
Publicado: (2022)

Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital
por: Paulino Pereira, Leonor J., et al.
Publicado: (2023)

A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer
por: Tsaur, Igor, et al.
Publicado: (2021)

Prostate Cancer in Renal Transplant Recipients: Results from a Large Contemporary Cohort
por: Marra, Giancarlo, et al.
Publicado: (2022)

The SAFE Pilot Trial—SAlvage Focal Irreversible Electroporation—For Recurrent Localized Prostate Cancer: Rationale and Study Protocol
por: Marra, Giancarlo, et al.
Publicado: (2022)

Multimodale Therapie des Hochrisiko- und lokal fortgeschrittenen Prostatakarzinoms
por: Preisser, Felix, et al.
Publicado: (2022)

Histological outcomes after focal high-intensity focused ultrasound and cryotherapy
por: Shah, Taimur T., et al.
Publicado: (2015)

Anatomical Fundamentals and Current Surgical Knowledge of Prostate Anatomy Related to Functional and Oncological Outcomes for Robotic-Assisted Radical Prostatectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions
por: Zattoni, Fabio, et al.
Publicado: (2023)

The impact of a second MRI and re-biopsy in patients with initial negative mpMRI-targeted and systematic biopsy for PIRADS ≥ 3 lesions
por: Zattoni, Fabio, et al.
Publicado: (2023)

AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy
por: Oh, Su Jung, et al.
Publicado: (2017)

Molecular Mechanisms Related with Oligometastatic Prostate Cancer—Is It Just a Matter of Numbers?
por: Surcel, Cristian, et al.
Publicado: (2022)

There Is No Longer a Role for Systematic Biopsies in Prostate Cancer Diagnosis
por: Kasivisvanathan, Veeru, et al.
Publicado: (2022)

The Role of Lymph Node Dissection in the Treatment of Bladder Cancer
por: Cattaneo, Francesco, et al.
Publicado: (2018)

Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
por: Rakauskas, Arnas, et al.
Publicado: (2021)

Pre-biopsy MRI as an adjunct for cancer detection in men with elevated PSA and no previous biopsy
por: Uriburu-Pizarro, Facundo, et al.
Publicado: (2017)

Childhood motocross truncal injuries: high-velocity, focal force to the chest and abdomen
por: Kennedy, Raelene D, et al.
Publicado: (2012)

Focal Therapy for Prostate Cancer: Rationale and Treatment Opportunities
por: Kasivisvanathan, V., et al.
Publicado: (2013)

En Bloc Resection of Bladder Tumor—Is It the Way Forward?
por: Fankhauser, Christian Daniel, et al.
Publicado: (2021)

Case report: Pylorus-preserving pancreatoduodenectomy for focal congenital hyperinsulinism in a 5-month-old baby
por: Spagnoletti, Gionata, et al.
Publicado: (2023)

Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study
por: Rakauskas, Arnas, et al.
Publicado: (2023)

Assessment of a novel smartglass-based point-of-care fusion approach for mixed reality-assisted targeted prostate biopsy: A pilot proof-of-concept study
por: Sparwasser, P., et al.
Publicado: (2022)

Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer
por: Preisser, Felix, et al.
Publicado: (2021)

MRI-Fusion Targeted vs. Systematic Prostate Biopsy–How Does the Biopsy Technique Affect Gleason Grade Concordance and Upgrading After Radical Prostatectomy?
por: Rührup, Jessica, et al.
Publicado: (2019)

Spermatic Cord Sarcoma: A 20-Year Single-Institution Experience
por: Iafrate, Massimo, et al.
Publicado: (2020)

A rare case of multi-focal angiomyolipoma affecting the pancreas and liver
por: Bhardwaj, N, et al.
Publicado: (2012)

Complete Remission in Metastatic Pheochromocytoma Treated with Extensive Surgery
por: Arnas-Leon, Claudia, et al.
Publicado: (2016)

P40 Cross-specialty collaboration in the development of a national survey of practice for emergency scrotal exploration
por: Boam, Tristan, et al.
Publicado: (2021)

Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial Data
por: Remmers, Sebastiaan, et al.
Publicado: (2021)

The Effect of Adverse Patient Characteristics on Perioperative Outcomes in Open and Robot-Assisted Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2020)

Very Early Continence After Radical Prostatectomy and Its Influencing Factors
por: Theissen, Lena, et al.
Publicado: (2019)

Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l3t85gc5c33j79o63kr28nkfdh